Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor. Precision Medicine Communications, [S. l.], v. 3, n. 1, p. 27–42, 2023. DOI: 10.55627/pmc.003.01.0296. Disponível em: https://rootspress.org/journals/PMC/article/view/296. Acesso em: 2 apr. 2026.